Skip to main content
. 2017 Jun 19;19:71. doi: 10.1186/s13058-017-0864-z

Fig. 1.

Fig. 1

Comparison of chemokine score with (a) molecular subtype and (b) immunohistochemistry (IHC). ER estrogen receptor, HER2 human epidermal growth factor receptor 2, TNBC triple-negative breast cancer